Acute Kidney Injury after Endovascular Procedures: How to Avoid this Old Foe

Author(s): Nikolaos Patelis.

Journal Name: Current Pharmaceutical Design

Volume 25 , Issue 44 , 2019

Become EABM
Become Reviewer

[1]
Vlachopanos G, Schizas D, Hasemaki N, Georgalis A. Pathophysiology of contrast-induced acute kidney injury (CIAKI). Curr Pharm Des 2019; 25(44): 4642-7.
[2]
Vergadis C, Festas F, Spathi E, Pappas P, Spiliopoulos S. Methods for reducing contrast use and avoiding acute kidney injury during endovascular procedures. Curr Pharm Des 2019; 25(44): 4648-55.
[3]
Patelis N, Doulaptsis M, Kykalos S, Spartalis E, Maskanakis A, Georgopoulos S. Physiology of intraluminal administration of Carbon Dioxide as a contrast medium. Curr Pharm Des 2019; 25(44): 4656-61.
[4]
Bisdas T, Koutsias S. Carbon dioxide as standard of care for zero contrast interventions: when, why and how? Curr Pharm Des 2019; 25(44): 4662-6.
[5]
Bates KM, Ghanem H, Hague J, Matheiken SJ. Standardisation of technique and volume of iodinated contrast administration during infrainguinal angioplasty. Curr Pharm Des 2019; 25(44): 4667-74.
[6]
Nana P, Kouvelos G, Brotis A, Spanos K, Giannoukas A, Matsagkas M. The effect of endovascular aneurysm repair on renal function in patients treated for abdominal aortic aneurysm. Curr Pharm Des 2019; 25(44): 4675-85.
[7]
Liang NL, Mohapatra A, Avgerinos ED, Katsargyris A. Acute kidney injury after complex endovascular aneurysm repair. Curr Pharm Des 2019; 25(44): 4686-94.
[8]
Karaolanis G, Williams ZF, Bakoyiannis C, Hadjis D, Cox MW, Moris D. The clinical utility and assessment of renal biomarkers in acute kidney injury after abdominal endovascular aneurysm repair. A Systematic Review. Curr Pharm Des 2019; 25(44): 4695-701.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 25
ISSUE: 44
Year: 2019
Page: [4641 - 4641]
Pages: 1
DOI: 10.2174/138161282544191230152857

Article Metrics

PDF: 20
HTML: 2